Health Course of Patients Undergoing Per os Anti-cancer Therapy. (MinOS)
Multidisciplinary Consultation at the GHM Hospital of Grenoble (France) for the Establishment of an Oral Anti-cancer Drug Therapy : Feasibility, Security, and Evaluation of Patients' and City Health Professionals' Satisfaction.
Sponsor: Fondation de l'Avenir
This NA trial investigates Cancer and is currently completed. Fondation de l'Avenir leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2020 — Aug 2020 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Sep 2018 — Mar 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondation de l'Avenir
- Groupe Hospitalier Mutualiste de Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .